Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2007; 13(21): 2952-2955
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2952
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2952
Size ofHCC(cm) | n | Completenecrosis(% of patients) | Number oftreatments(mean ± SD) |
≤ 2.0 | 51 | 69 | 2.0 ± 1.5 |
2.1-3.0 | 35 | 69 | 2.2 ± 1.7 |
3.1-4.0 | 29 | 52 | 2.7 ± 2.0 |
4.1-5.0 | 22 | 68 | 2.8 ± 1.6 |
5.1-6.0 | 11 | 50 | 2.0 ± 1.3 |
> 6.0 | 14 | 13 | 3.3 ± 2.1 |
Size ofHCC (cm) | 12 mosurvival (%) | 24 mosurvival (%) | 36 mosurvival (%) |
≤ 2.0 | 87 | 87 | 79 |
2.1-3.0 | 85 | 67 | 54 |
3.1-4.0 | 72 | 58 | 50 |
4.1-5.0 | 88 | 59 | 49 |
5.1-6.0 | 78 | 45 | 30 |
> 6.0 | 77 | 53 | 26 |
- Citation: Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol 2007; 13(21): 2952-2955
- URL: https://www.wjgnet.com/1007-9327/full/v13/i21/2952.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i21.2952